Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
As of 31.12.2022 GLR's cash reserve was £3,309,842. Anyone posting otherwise is either uninformed or deliberately attempting to mislead others for unknown reasons.
https://galileoresources.com/wp-content/uploads/GLR-Interims-30Dec2022.pdf
£3m in the bank …
Not interested in VB's pram rattling but I am interested in this - https://twitter.com/Jubilee_Metals/status/1651150624401022976?s=20
Pan predicted a fall not a rise, doesn’t read RNSs and should know charts are just a share pickers horoscope and about as accurate.
Pan … who predicted a fall in the share price and said GLR is skint.
Now deflects and still doesn’t read RNSs or end of year accounts.
Pan …
You have predicted a declining SP and declared GLR has no money. FACT
Trial results were excellent, that is what matters …
The only reason anyone will disparage another is because the commentators didn’t get what they want. It’s not a logical place to look if you are seeking unbiased information which can be found in balance sheets and RNSs.
VB you are seeking patterns.
Investing for me is about value not the market perception of the masses. As I see it GLR is very undervalued with 10 projects in hand and most at a point of inflection.
I have no interest in the opinions of others as I read the RNS's and look at the financial status of GLR.
May I suggest you read the RNSs in preference to the utterances of speculators.
When ... read the RNS's for yourself and work it out for yourself VB.
When GLR becomes cash generative the market will see this and then it will be too late for most speculators.
What do other companies have to do with GLR VB?
GLR has ample funding and multiple live projects. All other companies have their own unique issues and comparing GLR with others simply because CB is an element is tenuous.
You are looking for patterns that don't exist.
Will Pan be back as the share price inevitably rises ?
Pan your agenda is very clear. It is not only GLR that has a suppressed share valuation on the AIM. Your viewpoint is either ignorant or deliberately misleading. You will move in soon enough so play your games but all the facts reveal how wrong you are.
Let’s say that promotion of positive trials is a good thing regardless.
Promotion of trial results which have shown excellent results is never pointless.
Just launched … maybe a sign of better times are coming
https://twitter.com/nuformixplc/status/1640613799760674817?s=46&t=tUQTeRa0gKopv5Y7MfSmIA
Understanding the performance of new IPF therapies with SoC's has become critical to both potential development partners and regulators. Therefore, the Company believes completion of these steps is required for Nuformix to secure the interest of out-licensing partners.
More to do but looking promising.
I would be cautious of a prediction of a cure. The primary factor will be the level of impaired lung function in a patient due to historic inflammation. What 002 may offer is a limitation to the progression of the disease process and improved long term outcomes if the condition is treated early enough.
If near ablation can be achieved in practice this will be a game changer.
Reposting this as the graphic is an excellent resume of GLR's current assets and status.
Worth a screengrab as we have 10 projects and I get lost sometimes with all the detail.
https://twitter.com/Helioschariot/status/1639607413085970435
Concordia ... I was waiting for VB to use that one. Sure that's it Concorida.
Hmmmmmmm